AB
Alon Ben-Noon bought $200K of NRSN stock
Alon Ben-Noon, Chief Executive Officer of NeuroSense Therapeutics Ltd. (NRSN), bought 250,000 shares of NRSN stock worth $200K, per an SEC Form 4 filed Jun 17, 2026.
The shares came through a private deal, not the open market.
The trade happened on Jun 16, 2026, 1 day before it was made public.
NRSN has moved -90.8% since the trade date, from $13.98 to $1.28 (Nov 20, 2026 close).
- Traded
- Jun 16, 2026
- Disclosed
- Jun 17, 2026
- Filing delay
- 1 day
- Price since
- -90.8%
- Role
- Chief Executive Officer
- Source
- SEC Form 4